Page 115 - நாஸ்டாக் உலகளாவிய தேர்ந்தெடுக்கவும் சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

‘Biofacturing’ Firm Zymergen Raises $500 Million in Expanded IPO Bloomberg 3 hrs ago © Bloomberg An employee displays test tubes containing oil samples (Bloomberg) Zymergen Inc., which uses biological processes to manufacture chemicals, raised $500 million in an upsized initial public offering priced at the top of a marketed range. Popular Searches The company sold 16.13 million shares Wednesday for $31 each, according to a statement. It had marketed 13.6 million shares for $28 to $31. Zymergen has market value of about $3 billion based on the outstanding shares listed in its filings with the U.S. Securities and Exchange Commission. Including employee stock options, that valuation rises to more than $3.2 billion.

Exchange commissionBloomberg zymergen incJpmorgan chase coGoldman sachs group incCalifornia based zymergenGoldman sachs groupNasdaq global select marketபரிமாற்றம் தரகுஜுப்ம்ொர்கண் துரத்து இணைகோல்ட்மேன் சாக்ஸ் குழு இன்க்கோல்ட்மேன் சாக்ஸ் குழுநாஸ்டாக் உலகளாவிய தேர்ந்தெடுக்கவும் சந்தை